Skip to main content

Veracyte

Events
  • Live Events
  • On Demand Events
Search
Sign Up
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout

Helping patients understand their risk of recurrence scores

  • Overview
  • Resources

Thank you

This live web event has ended. Thank you for attending.

Description

We invite you to join our live discussion looking at ways to help breast cancer patients understand their risk of recurrence scores. Professor Dame Lesley Fallowfield will talk about the TARGET educational programme and then move on to the IMPARTER study that examines if provision of a specific patient information film improves knowledge about gene expression profiling (GEP) and enhances satisfaction with patient-clinician discussions.

Contributors

  • Professor Dame Lesley Fallowfield, Director of SHORE-C and Professor of Psycho-Oncology

    Dame Lesley Fallowfield is Professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex where she is Director of the Sussex Health Outcomes Research & Education in Cancer (SHORE-C) group. Dame Lesley originally trained as a nurse at Guy’s Hospital, London but then did a BSc in Experimental Psychology at Sussex. Research for her doctorate examining the perceptual correlates of optic nerve damage in demyelinating diseases was completed at the Universities of Sussex and Cambridge. In 1991 she became the full-time Director of a Psychosocial Oncology Group and was awarded the first European Chair in Psycho-oncology from University College, London in 1997. Her research interests are wide and include the measurement of quality of life in clinical trials of cancer therapy and the training of communication skills for health care professionals in cancer. She has published over 400 papers, many book chapters and 3 text books. She lectures and runs training workshops throughout the world in psychosocial oncology, quality of life assessment and communication skills. She is a Fellow of the UK Academy of Medical Sciences and was made a Dame Commander of the Order of the British Empire in 2016.

  • Sam Jole

    Sam Jole is the associate Medical affairs director for Veracyte across Northern Europe where he provides medical and scientific support to the community to help improve understanding and access to genomic testing for breast cancer patients and is part of a wider team whom are here to help HCPs with clinical, scientific or access related questions.

  • Visit our Prosigna website

    https://www.prosigna.com/

March 1, 2023
Wed 6:00 PM CET

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136
Register
Log In
  • New
  • Existing

Forgot password?
  • Events
  • Search
  • Support
  • Sign Up
  • Sign In
  • Privacy Policy | Terms and Conditions